Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine
Xintao Hu, Krithika P. Karthigeyan, Savannah Herbek, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 2, pp. 455-466
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Nucleic acid drugs: recent progress and future perspectives
Xiaoyi Sun, Sarra Setrerrahmane, Chencheng Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
A vaccine against cytomegalovirus: how close are we?
Sallie R. Permar, Mark R. Schleiss, S. A. Plotkin
Journal of Clinical Investigation (2025) Vol. 135, Iss. 1
Closed Access | Times Cited: 1
Expanding the Potential of Circular RNA (CircRNA) Vaccines: A Promising Therapeutic Approach
Tian Bu, Wenlong Yang, Jian Zhao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 379-379
Open Access | Times Cited: 1
How Immunocompromised Hosts Were Left Behind in the Quest to Control the Covid-19 Pandemic
Michael Boeckh, Steven A. Pergam, Ajit P. Limaye, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 7
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Prospects and Challenges in Developing mRNA Vaccines for Infectious Diseases and Oncogenic Viruses
L. V. Simhachalam Kutikuppala, Islam Kourampi, Ramya S. D. Kanagala, et al.
Medical Sciences (2024) Vol. 12, Iss. 2, pp. 28-28
Open Access | Times Cited: 5
The Platform Technology Approach to mRNA Product Development and Regulation
John Howard Skerritt, Carolyn Tucek-Szabo, Brett Sutton, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 528-528
Open Access | Times Cited: 4
Provider‐Led Interventions to Reduce Congenital Cytomegalovirus
Erin Trisko, Kayla Gosnell, Tonia Douglas, et al.
Journal of Midwifery & Women s Health (2025)
Open Access
The Fight Continues: Virus Without Vaccines
Van G. Wilson
(2025), pp. 373-391
Closed Access
Smart nucleic acid nanodrug delivery system for precision therapeutics
Yu Chen, Zongkang Guo, Jing Li, et al.
Coordination Chemistry Reviews (2025) Vol. 535, pp. 216673-216673
Closed Access
Truncated rotavirus VP4 proteins induce stronger protective immunity compared to P2 - VP8 in animal models
Yaling Chen, Guoxing Luo, Feibo Song, et al.
Antiviral Research (2025), pp. 106156-106156
Closed Access
Developing a Vaccine Against Human Cytomegalovirus: Identifying and Targeting HCMV’s Immunological Achilles’ Heel
Anastasia Lankina, Marta Brezmes Raposo, Alexander Hargreaves, et al.
Vaccines (2025) Vol. 13, Iss. 5, pp. 435-435
Open Access
The Platform Technology Approach to mRNA Product Development and Regulation
John Howard Skerritt, Carolyn Tucek-Szabo, Brett Sutton, et al.
(2024)
Open Access | Times Cited: 3
Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation
Tang‐Her Jaing, Yi-Lun Wang, Chia-Chi Chiu
Viruses (2024) Vol. 16, Iss. 8, pp. 1268-1268
Open Access | Times Cited: 2
Burden of Congenital CMV Infection: A Narrative Review and Implications for Public Health Interventions
Cecilia Liberati, Giulia Sturniolo, Giulia Brigadoi, et al.
Viruses (2024) Vol. 16, Iss. 8, pp. 1311-1311
Open Access | Times Cited: 2
Auditory and Vestibular Involvement in Congenital Cytomegalovirus Infection
Swetha Pinninti, W. J. Britt, Suresh B. Boppana
Pathogens (2024) Vol. 13, Iss. 11, pp. 1019-1019
Open Access | Times Cited: 2
Human cytomegalovirus: pathogenesis, prevention, and treatment
Zifang Shang, Xin Li
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2
Innate and adaptive effector immune drivers of cytomegalovirus disease in lung transplantation: a double-edged sword
Reena Bharti, Daniel R. Calabrese
Frontiers in Transplantation (2024) Vol. 3
Open Access | Times Cited: 1
Maternal Immunizations: Past, Present, and Future
Anne-Marie Rick, Richard H. Beigi
Clinical Obstetrics & Gynecology (2024) Vol. 67, Iss. 3, pp. 605-619
Closed Access | Times Cited: 1
The EEHV1A gH/gL complex elicits humoral and cell-mediated immune responses in mice
Jennifer L. Spencer Clinton, Tabitha E. Hoornweg, Jie Tan, et al.
Vaccine (2024) Vol. 42, Iss. 23, pp. 126227-126227
Closed Access | Times Cited: 1
mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases
Rossella Brandi, Alessia Paganelli, Raffaele D’Amelio, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1418-1418
Open Access | Times Cited: 1
Vaccinations in nephrology
Christian Weber, S. Jansen, Hana Rohn, et al.
Deleted Journal (2024) Vol. 19, Iss. 4, pp. 201-211
Closed Access
Perinatal Vaccination by Transamniotic Fetal mRNA Delivery: Immunization Against Human Cytomegalovirus in a Rodent Model
Kamila Moskowitzova, Abbie E. Naus, Savas T. Tsikis, et al.
Journal of Pediatric Surgery (2024), pp. 161956-161956
Closed Access
A human cytomegalovirus prefusion-like glycoprotein B subunit vaccine elicits similar humoral immunity to that of postfusion gB in mice
Krithika P. Karthigeyan, Megan Connors, Christian Binuya, et al.
(2024)
Closed Access
Current evidence gaps to support systematic cytomegalovirus screening in pregnancy
Agathe Billette De Villemeur, B Hoen, Éric Billaud, et al.
EClinicalMedicine (2024) Vol. 78, pp. 102941-102941
Open Access
Page 1 - Next Page

Scroll to top